Chrysovalantis Voutouri, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyaluronic Acid | 3 | 2018 | 491 | 0.970 |
Why?
|
Elasticity Imaging Techniques | 1 | 2023 | 388 | 0.640 |
Why?
|
Collagen | 6 | 2023 | 2688 | 0.530 |
Why?
|
Stress, Mechanical | 4 | 2017 | 1686 | 0.480 |
Why?
|
Neoplasms | 8 | 2024 | 21693 | 0.430 |
Why?
|
Tumor Microenvironment | 12 | 2023 | 3590 | 0.430 |
Why?
|
Edema | 1 | 2016 | 789 | 0.430 |
Why?
|
Nanomedicine | 4 | 2022 | 304 | 0.370 |
Why?
|
Immunotherapy | 7 | 2023 | 4445 | 0.330 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2638 | 0.320 |
Why?
|
Micelles | 3 | 2023 | 203 | 0.310 |
Why?
|
Cell Line, Tumor | 12 | 2023 | 16692 | 0.290 |
Why?
|
Pyridones | 3 | 2023 | 712 | 0.260 |
Why?
|
Breast Neoplasms | 6 | 2020 | 20823 | 0.260 |
Why?
|
Models, Biological | 4 | 2018 | 9584 | 0.260 |
Why?
|
Melanoma | 1 | 2023 | 5511 | 0.250 |
Why?
|
Glioblastoma | 1 | 2019 | 3481 | 0.230 |
Why?
|
Extracellular Matrix | 5 | 2020 | 1741 | 0.230 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2542 | 0.210 |
Why?
|
Elastic Modulus | 2 | 2023 | 214 | 0.200 |
Why?
|
Perfusion | 2 | 2023 | 1360 | 0.190 |
Why?
|
Nanocomposites | 1 | 2020 | 52 | 0.180 |
Why?
|
Keratinocytes | 1 | 2024 | 799 | 0.180 |
Why?
|
Focal Adhesions | 1 | 2020 | 121 | 0.170 |
Why?
|
Models, Immunological | 1 | 2022 | 527 | 0.170 |
Why?
|
Tumor Burden | 2 | 2023 | 1915 | 0.170 |
Why?
|
Cadherins | 1 | 2024 | 907 | 0.170 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2020 | 176 | 0.170 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13695 | 0.160 |
Why?
|
Magnetite Nanoparticles | 1 | 2020 | 321 | 0.160 |
Why?
|
Angiopoietin-2 | 1 | 2019 | 172 | 0.160 |
Why?
|
Models, Theoretical | 3 | 2021 | 3589 | 0.160 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8862 | 0.150 |
Why?
|
Mice, Nude | 3 | 2019 | 3689 | 0.150 |
Why?
|
Osteosarcoma | 1 | 2022 | 881 | 0.150 |
Why?
|
Mice | 13 | 2023 | 81202 | 0.140 |
Why?
|
Osmotic Pressure | 1 | 2016 | 151 | 0.140 |
Why?
|
Mammary Glands, Animal | 1 | 2018 | 276 | 0.140 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2019 | 520 | 0.140 |
Why?
|
Collagenases | 1 | 2016 | 228 | 0.140 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 1978 | 0.130 |
Why?
|
Spheroids, Cellular | 1 | 2016 | 351 | 0.120 |
Why?
|
Drug Carriers | 1 | 2019 | 693 | 0.120 |
Why?
|
Transforming Growth Factor beta | 2 | 2020 | 2007 | 0.120 |
Why?
|
Neoplasm Transplantation | 1 | 2018 | 2086 | 0.120 |
Why?
|
Microscopy | 1 | 2019 | 902 | 0.110 |
Why?
|
Nanoparticles | 3 | 2020 | 1905 | 0.110 |
Why?
|
Cisplatin | 1 | 2019 | 1662 | 0.110 |
Why?
|
Particle Size | 1 | 2017 | 1642 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5263 | 0.110 |
Why?
|
Hedgehog Proteins | 1 | 2017 | 783 | 0.110 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6387 | 0.110 |
Why?
|
Angiogenesis Inhibitors | 2 | 2020 | 2038 | 0.100 |
Why?
|
Animals | 14 | 2023 | 168770 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18034 | 0.100 |
Why?
|
Dexamethasone | 1 | 2019 | 1951 | 0.100 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 502 | 0.100 |
Why?
|
Vaccination | 1 | 2024 | 3279 | 0.100 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3177 | 0.100 |
Why?
|
Disease Progression | 2 | 2021 | 13285 | 0.100 |
Why?
|
Materials Testing | 1 | 2014 | 867 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3616 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2022 | 2530 | 0.090 |
Why?
|
Computer Simulation | 2 | 2021 | 6194 | 0.090 |
Why?
|
Humans | 17 | 2024 | 744376 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2021 | 2962 | 0.080 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6314 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3511 | 0.080 |
Why?
|
Doxorubicin | 3 | 2020 | 2234 | 0.070 |
Why?
|
Oxygen | 1 | 2019 | 4189 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2018 | 3280 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7323 | 0.070 |
Why?
|
Phenotype | 1 | 2021 | 16367 | 0.060 |
Why?
|
Immunologic Factors | 2 | 2022 | 1580 | 0.050 |
Why?
|
Polyethylene Glycols | 2 | 2020 | 1182 | 0.050 |
Why?
|
Rats | 1 | 2019 | 24252 | 0.050 |
Why?
|
Microscopy, Atomic Force | 1 | 2023 | 250 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2015 | 10484 | 0.050 |
Why?
|
Drug Delivery Systems | 3 | 2017 | 2219 | 0.050 |
Why?
|
Down-Regulation | 2 | 2020 | 3001 | 0.050 |
Why?
|
Elasticity | 1 | 2023 | 657 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19905 | 0.050 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2020 | 85 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2024 | 1185 | 0.040 |
Why?
|
beta Catenin | 1 | 2024 | 1059 | 0.040 |
Why?
|
Female | 8 | 2022 | 380200 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2024 | 3144 | 0.040 |
Why?
|
Collagen Type I | 1 | 2020 | 592 | 0.040 |
Why?
|
Actins | 1 | 2024 | 2121 | 0.030 |
Why?
|
Extracellular Fluid | 1 | 2017 | 167 | 0.030 |
Why?
|
Polymers | 1 | 2022 | 1621 | 0.030 |
Why?
|
Immunization | 1 | 2020 | 1256 | 0.030 |
Why?
|
Hydrogels | 1 | 2020 | 724 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 1958 | 0.030 |
Why?
|
Anilides | 1 | 2017 | 408 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2015 | 431 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1879 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2020 | 10183 | 0.030 |
Why?
|
Mice, SCID | 1 | 2017 | 2717 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2020 | 3207 | 0.020 |
Why?
|
Skin | 1 | 2024 | 4371 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3556 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4851 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11525 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4162 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7914 | 0.020 |
Why?
|
Pyridines | 1 | 2017 | 2825 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9274 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11486 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8432 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 13882 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23406 | 0.010 |
Why?
|
Male | 2 | 2022 | 350118 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 63115 | 0.010 |
Why?
|
Aged | 1 | 2022 | 163284 | 0.010 |
Why?
|